Inmune Bio(INMB.US)

Last Updated 19:00:00 ET
longbridge loading

INmune Bio shares are trading higher after the company announced that the FDA granted the fast Track designation to XPro

benzinga_article·
US
INMB
-5.37%
US
BIB
+0.05%
US
PBE
+0.11%
benzinga_article·
US
INMB
-5.37%
US
BIB
+0.05%
US
PBE
+0.11%

Analysts Have Conflicting Sentiments on These Healthcare Companies: Inmune Bio (INMB) and Joint (JYNT)

businessinsider·
US
JYNT
-0.11%
US
INMB
-5.37%
US
IHF
-0.41%
businessinsider·
US
JYNT
-0.11%
US
INMB
-5.37%
US
IHF
-0.41%

Inmune Bio | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
INMB
-5.37%
Earnings Watch·
US
INMB
-5.37%

INmune Bio Expands Cord Tissue License for CORDStrom Platform

Tip Ranks·
US
INMB
-5.37%
US
LABU
-2.35%
US
XBI
-0.69%
Tip Ranks·
US
INMB
-5.37%
US
LABU
-2.35%
US
XBI
-0.69%

Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs

benzinga_article·
US
ARKG
+0.04%
US
INMB
-5.37%
US
XBI
-0.69%
benzinga_article·
US
ARKG
+0.04%
US
INMB
-5.37%
US
XBI
-0.69%

Inmune Bio Earnings Call Balances Progress and Risk

Tip Ranks·
US
XBI
-0.69%
US
BIB
+0.05%
US
LABU
-2.35%
Tip Ranks·
US
XBI
-0.69%
US
BIB
+0.05%
US
LABU
-2.35%
© 2026 Longbridge｜Disclaimer